IRIS
PENNISI, MARIA STELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 952
EU - Europa 523
AS - Asia 390
SA - Sud America 169
AF - Africa 118
OC - Oceania 1
Totale 2.153
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 939
IT - Italia 251
SG - Singapore 190
BR - Brasile 157
IE - Irlanda 95
CN - Cina 91
CI - Costa d'Avorio 74
DE - Germania 52
IN - India 40
SN - Senegal 34
VN - Vietnam 28
RU - Federazione Russa 26
FI - Finlandia 21
GB - Regno Unito 15
BE - Belgio 12
CA - Canada 10
CZ - Repubblica Ceca 8
SE - Svezia 8
TR - Turchia 7
UZ - Uzbekistan 7
UA - Ucraina 6
IQ - Iraq 5
AR - Argentina 4
CH - Svizzera 4
FR - Francia 4
JP - Giappone 4
NO - Norvegia 4
PL - Polonia 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
IL - Israele 3
MA - Marocco 3
MX - Messico 3
BD - Bangladesh 2
CO - Colombia 2
ES - Italia 2
GR - Grecia 2
HK - Hong Kong 2
KR - Corea 2
NG - Nigeria 2
NL - Olanda 2
TN - Tunisia 2
ZA - Sudafrica 2
AL - Albania 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
LU - Lussemburgo 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UY - Uruguay 1
Totale 2.153
Salva come PNG Salva come JPEG
Città #
Santa Clara 209
Chandler 194
Singapore 124
Chicago 101
Dublin 95
Abidjan 74
Catania 60
Civitanova Marche 34
Dakar 34
Ashburn 33
Kochi 32
Boardman 31
Cambridge 27
Lawrence 25
Andover 24
Grafing 23
Dong Ket 22
Wilmington 17
Munich 16
The Dalles 15
Des Moines 14
Beijing 13
Columbus 13
Brussels 12
Council Bluffs 12
Turku 12
Palermo 11
São Paulo 11
Nanjing 10
New York 10
Los Angeles 9
Santa Venerina 9
Belo Horizonte 8
Brno 8
Helsinki 8
Bari 7
Hanoi 6
Milan 6
Pune 6
Aci Catena 5
Seattle 5
Toronto 5
Bremen 4
Edinburgh 4
Falls Church 4
Frankfurt am Main 4
Giardini-Naxos 4
Houston 4
Jiaxing 4
Saint Petersburg 4
Tokyo 4
Tremestieri Etneo 4
Catanzaro 3
Fantina 3
Guarulhos 3
Hanover 3
Hefei 3
Jinan 3
Manaus 3
Messina 3
Oslo 3
Rio de Janeiro 3
San Giovanni la Punta 3
Tashkent 3
Volta Redonda 3
Woodbridge 3
Abuja 2
Baghdad 2
Belém 2
Blumenau 2
Cabo Frio 2
Campo Grande 2
Casablanca 2
Comiso 2
Cáceres 2
Dubai 2
Fairfield 2
Istanbul 2
Jacksonville 2
Johannesburg 2
Joinville 2
London 2
Madrid 2
Manchester 2
Marília 2
Mascali 2
Mexico City 2
Montreal 2
Moscow 2
Nanchang 2
Newham 2
Ottawa 2
Quito 2
Sant'Agata di Militello 2
Seoul 2
Siracusa 2
São Bernardo do Campo 2
Toledo 2
Zhengzhou 2
Abingdon 1
Totale 1.539
Salva come PNG Salva come JPEG
Nome #
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 154
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia 115
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment 104
BCR-ABL1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors 90
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice 89
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives 88
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 87
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report 87
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 85
New insights in thyroid cancer and p53 family proteins 84
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report 83
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report 83
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) 80
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts 78
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report 76
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 76
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports 74
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib 73
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 73
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 71
Opportunities and challenges of liquid biopsy in thyroid cancer 68
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 67
Rapid decline of philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report 62
Targeting BCL-2 as a therapeutic strategy for primary p210BCR-ABL1-positive B-ALL cells 62
Molecular pathogenesis and treatment perspectives for hypereosinophilia and hypereosinophilic syndromes 60
The Role of New Technologies in Myeloproliferative Neoplasms 57
Multiple primary malignances managed with surgical excision: a case report with next generation sequencing analysis 52
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability 46
Totale 2.224
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.188
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.188
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021113 10 0 3 10 23 5 2 2 26 2 3 27
2021/2022184 1 33 6 3 37 4 30 6 7 1 12 44
2022/2023515 29 46 23 68 28 75 3 108 98 5 23 9
2023/2024299 21 49 11 9 10 76 2 19 2 11 68 21
2024/2025959 13 154 38 87 187 132 97 30 31 46 113 31
2025/202624 24 0 0 0 0 0 0 0 0 0 0 0
Totale 2.224